Alx Oncology Holdings (ALXO) Change in Account Payables (2019 - 2026)

Alx Oncology Holdings (ALXO) has 8 years of Change in Account Payables data on file, last reported at -$1.2 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Account Payables fell 117.63% year-over-year to -$1.2 million; the trailing twelve-month figure through Mar 2026 stood at -$233000.0 (up 89.66% YoY), and the FY2025 full-year result was $421000.0, up 110.46% from the prior year.
• Change in Account Payables climbed to -$1.2 million in Q1 2026, from -$1.7 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $8.9 million in Q3 2023 to a low of -$5.7 million in Q2 2023.
• A 5-year average of $8882.4 and a median of -$194000.0 in 2024 frame the typical range for Change in Account Payables.
• Across the five-year window, Change in Account Payables sank 282.72% in 2023 and surged 966.49% in 2025, its largest moves.
• Tracing ALXO's Change in Account Payables over 5 years: stood at $2.5 million in 2022, then slumped by 282.72% to -$4.5 million in 2023, then gained by 24.46% to -$3.4 million in 2024, then surged by 50.72% to -$1.7 million in 2025, then advanced by 27.5% to -$1.2 million in 2026.
• Business Quant data shows ALXO's Change in Account Payables at -$1.2 million in Q1 2026, -$1.7 million in Q4 2025, and $1.7 million in Q3 2025.